首页> 外文期刊>International Journal of Nanomedicine >Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
【24h】

Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats

机译:辛莫莫酚加载的PLGA纳米柱,用于加速伤口愈合在大鼠糖尿病足溃疡中的伤口愈合

获取原文
           

摘要

Background:Diabetic foot ulcer is an intractable complication of diabetes, characterized by the disturbed inflammatory and proliferative phases of wound healing. Sesamol, a phenolic compound, has been known for its powerful antioxidant, anti-inflammatory, anti-hyperglycaemic and wound healing properties. The aim of the present study was to develop a sesamol nano formulation and to study its effect on the various phases of the wound healing process in diabetic foot condition.Methods:Sesamol-PLGA (SM-PLGA) nanosuspension was developed ?using nanoprecipitation method. TEM, in vitro drug release assay and in vivo pharmacokinetic studies were performed for the optimised formulation. Diabetic foot ulcer (DFU) in high fat diet (HFD)-fed streptozotocin-induced type-II diabetic animal model was used to assess the SM-PLGA nanosuspension efficacy. SM-PLGA nanosuspension was administered by oral route. TNF-α levels were estimated using ELISA and Western blot analysis was performed to assess the effect on the expression of HSP-27, ERK, PDGF-B and VEGF in wound tissue. Wound re-epithelization, fibroblast migration, collagen deposition and inflammatory cell infiltration were assessed by H&E and Masson's trichrome staining. Effect on angiogenesis was assessed by CD-31 IHC staining in wound sections.Results:The optimized SM-PLGA nanosuspension had an average particle size of 300 nm, PDI0.200 with spherical shaped particles. Approximately 80% of the drug was released over a period of 60 h in in vitro assay. Half-life of the formulation was found to be 13.947 ± 0.596 h. SM-PLGA nanosuspension treatment decreased TNF-α levels in wound tissue and accelerated the collagen deposition. Whereas, HSP-27, ERK, PDGF-B and VEGF expression increased and improved new blood vessels' development. Rapid re-epithelization, fibroblast migration, collagen deposition and reduced inflammatory cell infiltration at the wound site were also observed.Conclusion:Results indicate that sesamol-PLGA nanosuspension significantly promotes the acceleration of wound healing in diabetic foot ulcers by restoring the altered wound healing process in diabetic condition.? 2020 Gourishetti et al.
机译:背景:糖尿病足溃疡是糖尿病的难治性并发症,其特征在于受伤口愈合的干扰炎症和增殖阶段。 Sesamol,一种酚类化合物,已知是其强大的抗氧化剂,抗炎,抗高血糖和伤口愈合性能。本研究的目的是开发芝麻醇纳米制剂,并研究其对糖尿病足部条件下伤口愈合过程的各个阶段的影响。方法:SESAMOL-PLGA(SM-PLGA)纳米术纳米术ααSESAMOL-PLGA(SM-PLGGA)纳米术。使用纳米沉淀法。进行TEM,体外药物释放测定和体内药代动力学研究进行了优化的制剂。使用高脂饮食(HFD)的糖尿病足溃疡(DFU) - 用于评估SM-PLGA纳米杆菌的糖尿病患者的II型糖尿病动物模型。通过口服途径给药SM-PLGA纳米溶症。使用ELISA估计TNF-α水平,并进行Western印迹分析以评估对伤口组织中HSP-27,ERK,PDGF-B和VEGF的表达的影响。通过H&E和Masson的三色染色评估伤口重新上皮,成纤维细胞迁移,胶原沉积和炎症细胞浸润。通过伤口切片中的CD-31 IHC染色评估对血管生成的影响。结果:优化的SM-PLGA纳米悬念的平均粒度为<300nm,PDI <0.200,具有球形颗粒。在体外测定中,大约80%的药物在60小时内释放。该配方的半衰期被发现为13.947±0.596小时。 SM-PLGA纳米术治疗在伤口组织中降低TNF-α水平并加速胶原沉积。虽然,HSP-27,ERK,PDGF-B和VEGF表达增加和改善了新的血管发展。还观察到快速再上皮,成纤维细胞迁移,胶原沉积和伤口位点的降低的炎症细胞浸润。结论:结果表明,SESAMOL-PLGA纳米术通过恢复改变的伤口愈​​合过程而显着促进糖尿病足溃疡的伤口愈合加速度在糖尿病条件下。 2020 Gourishetti等。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号